Kotak Alternate Asset Managers (Kotak ALTS) has committed ₹40 crore to Mediversal Healthcare, aiming to fuel the company’s aggressive expansion plans in Eastern India. The investment comes via Kotak’s Life Science Fund I, which focuses on early to growth-stage players in healthcare and life sciences. 

Mediversal, founded in 2020 by Navneet Ranjan, Bhanu Pratap and Jayant Gandhi, operates a 200+ bed multi-specialty hospital in Patna and is now targeting further growth in Bihar and neighbouring districts. With this infusion, the company plans both organic expansion building new hospitals and inorganic growth through potential mergers or partnerships. 

Kotak ALTS says it is drawn to Mediversal’s “blend of clinical excellence, affordability and regional relevance.” Ashish Ranjan, Director at Kotak ALTS, added that Mediversal’s commitment to institutionalized, reliable medical care aligns with Kotak’s long-term value creation goals. 

For its part, Mediversal CEO Bhanu Pratap remarked that the investment “accelerates our expansion across Bihar and Eastern India  opening new hospitals to serve underserved communities with dignified care closer to home.”  He also noted that the capital will strengthen Mediversal’s technological foundation, enabling it to scale operations without compromising on quality. 

This round also saw participation from Asha Ventures, an impact-focused investor, signalling broader backing for Mediversal’s mission.The funding aligns with a larger trend in India where private equity is increasingly targeting healthcare firms that combine social impact with scalability.